Pharmacokinetics and Pharmacodynamics of Once-Weekly Somapacitan in Children and Adults: Supporting Dosing Rationales with a Model-Based Analysis of Three Phase I Trials

BACKGROUND: Somapacitan, a long-acting growth hormone (GH) derivative, has been well-tolerated in children with GH deficiency (GHD) and adults (healthy and adult GHD), in phase I, single- and multiple-dose trials, respectively, and has pharmacokinetic and pharmacodynamic properties supporting a once...

Descripción completa

Detalles Bibliográficos
Autores principales: Juul, Rasmus Vestergaard, Rasmussen, Michael Højby, Agersø, Henrik, Overgaard, Rune Viig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325982/
https://www.ncbi.nlm.nih.gov/pubmed/29671202
http://dx.doi.org/10.1007/s40262-018-0662-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325982/
https://www.ncbi.nlm.nih.gov/pubmed/29671202
http://dx.doi.org/10.1007/s40262-018-0662-5

Ejemplares similares